Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Borosil Scienti.
Quarter-by-quarter operating performance
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 88 | 92 | 100 | 116 | 104 | 103 | 101 | 129 | 96 | 107 | 121 | 143 |
| Expenses + | 82 | 82 | 88 | 97 | 94 | 87 | 91 | 113 | 91 | 99 | 104 | 111 |
| Operating Profit | 6 | 9 | 12 | 18 | 10 | 16 | 10 | 17 | 5 | 8 | 17 | 32 |
| OPM % | 7% | 10% | 12% | 16% | 9% | 15% | 10% | 13% | 5% | 8% | 14% | 22% |
| Other Income + | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | -4 | 2 | 0 | 2 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Profit before tax | 2 | 6 | 8 | 15 | 7 | 12 | 7 | 14 | -4 | 5 | 13 | 29 |
| Tax % | -36% | 20% | 30% | 35% | 28% | 29% | 38% | 39% | 3% | 44% | 31% | 7% |
| Net Profit + | 3 | 5 | 6 | 9 | 5 | 9 | 4 | 9 | -4 | 3 | 9 | 27 |
| EPS in Rs | 0.65 | 1.05 | 0.57 | 0.99 | 0.48 | 0.97 | -0.47 | 0.32 | 0.98 | 3.06 |
Financials of Borosil Scienti.
Annual income statement trend
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales + | 392 | 434 | 467 |
| Expenses + | 345 | 381 | 405 |
| Operating Profit | 47 | 53 | 62 |
| OPM % | 12% | 12% | 13% |
| Other Income + | 4 | 8 | 1 |
| Interest | 3 | 2 | 1 |
| Depreciation | 16 | 18 | 19 |
| Profit before tax | 32 | 40 | 43 |
| Tax % | 26% | 34% | 19% |
| Net Profit + | 23 | 27 | 35 |
| EPS in Rs | 2.65 | 3.01 | 3.89 |
| Dividend Payout % | 0% | 0% | 0% |
Financials of Borosil Scienti.
Capital structure and asset base
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 9 | 9 | 9 |
| Reserves | 367 | 395 | 432 |
| Borrowings + | 18 | 14 | 9 |
| Other Liabilities + | 95 | 86 | 99 |
| Total Liabilities | 488 | 504 | 549 |
| Fixed Assets + | 192 | 187 | 189 |
| CWIP | 1 | 1 | 9 |
| Investments | 0 | 105 | 122 |
| Other Assets + | 295 | 210 | 229 |
| Total Assets | 488 | 504 | 549 |
Financials of Borosil Scienti.
Operating, investing and financing cash movement
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from Operating Activity + | 30 | 120 | 43 |
| Cash from Investing Activity + | -2 | -115 | -37 |
| Cash from Financing Activity + | -16 | -3 | -6 |
| Net Cash Flow | 12 | 1 | -0 |
| Free Cash Flow | 17 | 106 | 16 |
| CFO/OP | 97% | 249% | 93% |
Financials of Borosil Scienti.
Working capital efficiency and return ratios
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 57 | 59 | 59 |
| Inventory Days | 244 | 218 | 226 |
| Days Payable | 102 | 79 | 93 |
| Cash Conversion Cycle | 200 | 199 | 192 |
| Working Capital Days | 165 | 86 | 179 |
| ROCE % | 10% | 12% |
PAT growth seen with recent quarters growing by ~85% YoY, indicating strong earnings momentum. Key concall takeaways from Rathi Steel & Power Ltd's Q1 FY27…
SKP is steadily increasing capacity from about 80-100 tons earlier to around 1,800 tons now, operating at ~80% utilization (Page 20). Key concall takeaways…
Q1 FY27 showed strong profitability with EBITDA margin improving to 16.29% and net profit margin to 9.18%. Key concall takeaways from Mitsu Chem Plast Ltd's Q1…
Current capacity expansion planned for 300-350 crores revenue, further growth through organic or inorganic expansion. Key concall takeaways from Simplex…